Aspen Technology and Emerson Invest in Their Pharma Digital Threads

Subscribe To Read This Insight

By Michael Larner | 2Q 2021 | IN-6109


Aspen Technology Acquires Camo Analytics, While Emerson Invests in Fluxa


Aspen Technology and Emerson have both been investing to expand their respective digital thread capabilities in the pharmaceutical vertical. In February, Emerson announced an equity investment in Fluxa, while Aspen Technology announced the acquisition of Camo Analytics in November 2020.

Data transparency is critical for pharmaceutical manufacturers to demonstrate adherence to regulations along the drug creation, manufacturing, and distribution processes. Fluxa provides Process & Knowledge Management (PKM) software and helps its customers manage process and product specifications throughout the lifetime of a drug. Camo Analytics enables pharmaceutical manufacturers and biotech firms to optimize their production and quality control processes. A digital thread encapsulates the need for manufacturers to manage and share data across organizations to demonstrate regulatory compliance and maximize production capabilities; industrial software vendors, such as Aspen Technology and Emerson, are looking to provide customers with the mechanisms for ac…

You must be a subscriber to view this ABI Insight.
To find out more about subscribing contact a representative about purchasing options.